Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Jun;11(6):1049–1055. doi: 10.1128/aac.11.6.1049

Uniform Susceptibility of Various Strains of Coccidioides immitis to Amphotericin B

M S Collins 1, D Pappagianis 1
PMCID: PMC352127  PMID: 879751

Abstract

The susceptibility of 12 strains of Coccidioides immitis to amphotericin B (amB) was studied in vitro and in vivo. The minimal inhibitory concentration (MIC) of the mycelial phase of these strains was 0.078 to 0.16 μg/ml after 3 days of incubation, but by 15 days all strains were inhibited by 2.5 μg/ml. Mice infected intraperitoneally with these strains were sucessfully treated with 0.5 mg of amB per kg per day. These strains included several studied by others and which reportedly varied widely in susceptibility (MIC from 0.24 to 24.01 μg/ml) to amB. Four of these strains representing this putative broad range of susceptibility were used to infect mice intranasally. Regardless of infecting strain, mice were sucessfully treated with 0.38, 0.75, and 1.5 mg/kg, but 0.19 mg/kg was only partially effective. Thus, in vivo as well as in vitro there was a uniform response of C. immitis strains to amB.

Full text

PDF
1049

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collins M. S. Inhibition of growth of Coccidioides immitis on Sabouraud medium containing polymyxin B. J Clin Microbiol. 1975 Mar;1(3):335–336. doi: 10.1128/jcm.1.3.335-336.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collins M. S., Pappagianis D. Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B. Sabouraudia. 1974 Nov;12(3):329–340. [PubMed] [Google Scholar]
  3. Collins M. S., Pappagianis D. Treatment of murine coccidioidomycosis with polymyxin B. Antimicrob Agents Chemother. 1976 Aug;10(2):318–321. doi: 10.1128/aac.10.2.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Collins S., Pappagians D. Inhibition of Coccidioides immitis in vitro and enhancement of antiococcidiodial effects of amphotericin B by polymyxin B. Antimicrob Agents Chemother. 1975 Jun;7(6):781–787. doi: 10.1128/aac.7.6.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drutz D. J., Spickard A., Rogers D. E., Koenig M. G. Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy. Am J Med. 1968 Sep;45(3):405–418. doi: 10.1016/0002-9343(68)90075-2. [DOI] [PubMed] [Google Scholar]
  6. Fields B. T., Jr, Bates J. H., Abernathy R. S. Amphotericin B serum concentrations during therapy. Appl Microbiol. 1970 Jun;19(6):955–959. doi: 10.1128/am.19.6.955-959.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HALDE C., NEWCOMER V. D., WRIGHT E. T., STERNBERG T. H. An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man. J Invest Dermatol. 1957 Mar;28(3):217-31; discussion, 231-2. doi: 10.1038/jid.1957.26. [DOI] [PubMed] [Google Scholar]
  8. Hoeprich P. D., Finn P. D. Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis. 1972 Oct;126(4):353–361. doi: 10.1093/infdis/126.4.353. [DOI] [PubMed] [Google Scholar]
  9. Hoeprich P. D., Huston A. C. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis. 1975 Aug;132(2):133–141. doi: 10.1093/infdis/132.2.133. [DOI] [PubMed] [Google Scholar]
  10. Huppert M., Pappagianis D., Sun S. H., Gleason-Jordan I., Collins M. S., Vukovich K. R. Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo. Antimicrob Agents Chemother. 1976 Mar;9(3):406–413. doi: 10.1128/aac.9.3.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LEVINE H. B., COBB J. M., SMITH C. E. Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines. Trans N Y Acad Sci. 1960 Apr;22:436–449. doi: 10.1111/j.2164-0947.1960.tb00711.x. [DOI] [PubMed] [Google Scholar]
  12. LITTMAN M. L., HOROWITZ P. L., SWADEY J. G. Coccidioidomycosis and its treatment with amphotericin B. Am J Med. 1958 Apr;24(4):568–592. doi: 10.1016/0002-9343(58)90297-3. [DOI] [PubMed] [Google Scholar]
  13. LOURIA D. B. Some aspects of the absorption, distribution, and excretion of amphotericin B in man. Antibiotic Med Clin Ther (New York) 1958 May;5(5):295–301. [PubMed] [Google Scholar]
  14. Levine H. B., Stevens D. A., Cobb J. M., Gebhardt A. E. Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro. J Infect Dis. 1975 Oct;132(4):407–414. doi: 10.1093/infdis/132.4.407. [DOI] [PubMed] [Google Scholar]
  15. PAPPAGIANIS D., KOBAYASHI G. S. Approaches to the physiology of Coccidioides immitis. Ann N Y Acad Sci. 1960 Aug 27;89:109–121. doi: 10.1111/j.1749-6632.1960.tb20135.x. [DOI] [PubMed] [Google Scholar]
  16. PAPPAGIANIS D., LEVINE H. B., SMITH C. E., BERMAN R. J., KOBAYASHI G. S. Immunization of mice with viable Cocidioides immitis. J Immunol. 1961 Jan;86:28–34. [PubMed] [Google Scholar]
  17. PAPPAGIANIS D., SMITH C. E., KOBAYASHI G. S. Relationship of the in vivo form of Coccidioides immitis to virulence. J Infect Dis. 1956 May-Jun;98(3):312–319. doi: 10.1093/infdis/98.3.312. [DOI] [PubMed] [Google Scholar]
  18. SANFORD W. G., RASCH J. R., STONEHILL R. B. A therapeutic dilemma. The treatment of disseminated coccidioidomycosis with amphotericin B. Ann Intern Med. 1962 Apr;56:553–563. doi: 10.7326/0003-4819-56-4-553. [DOI] [PubMed] [Google Scholar]
  19. SEABURY J. H., DASCOMB H. E. Experience with amphotericin B for the treatment of systemic mycoses. AMA Arch Intern Med. 1958 Dec;102(6):960–976. doi: 10.1001/archinte.1958.00260230106014. [DOI] [PubMed] [Google Scholar]
  20. SEABURY J. H., DASCOMB H. E. Experience with amphotericin B. Ann N Y Acad Sci. 1960 Aug 27;89:202–220. doi: 10.1111/j.1749-6632.1960.tb20143.x. [DOI] [PubMed] [Google Scholar]
  21. Shadomy S. In vitro antifungal activity of clotrimazole (Bay b 5097). Infect Immun. 1971 Aug;4(2):143–148. doi: 10.1128/iai.4.2.143-148.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stevens D. A., Levine H. B., Deresinski S. C. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. doi: 10.1016/0002-9343(76)90428-9. [DOI] [PubMed] [Google Scholar]
  23. Sung J. P., Grendahl J. G., Levine H. B. Intravenous and intrathecal miconazole therapy for systemic mycoses. West J Med. 1977 Jan;126(1):5–13. [PMC free article] [PubMed] [Google Scholar]
  24. TAYLOR R. L., LYNCH H. P., TAYLOR R. R., WEISER O. L. The determination of serum concentrations of amphotericin B in man. Am Rev Tuberc. 1958 Jun;77(6):1023–1025. doi: 10.1164/artpd.1958.77.6.1023. [DOI] [PubMed] [Google Scholar]
  25. WINN W. A. The use of amphotericin B in the treatment of coccidioidal disease. Am J Med. 1959 Oct;27:617–635. doi: 10.1016/0002-9343(59)90046-4. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES